Paracentesis following intravitreal drug injections in maintaining physiologic ocular perfusion pressure
Author:
Corresponding Author:

Timothy G. Murray. Murray Ocular Oncology & Retina, 6705 Red Road, Suite 412, Miami, FL 33143, USA. TMurray@murraymd.com

Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    A retrospective analysis was performed of patients who received a paracentesis immediately following an intravitreal injection of bevacizumab or triamcinolone acetonide. These patients were previously diagnosed as having glaucoma, ocular hypertension, or had responded previously with sustained elevated intraocular pressure. Of 1661 procedures were performed. Totally 219 (13%) of the injections were on phakic patients. A median (SD) of 210 μL (40 μL) of aqueous was removed during each paracentesis. There were no reported incidences of any complications. We propose performing a paracentesis immediately following intravitreal injections for patients at risk for ocular hypertension, glaucoma, and retinal vein or artery occlusion.

    Reference
    Related
    Cited by
Get Citation

Austin Bach, Artur Filipowicz, Aaron S. Gold, et al. Paracentesis following intravitreal drug injections in maintaining physiologic ocular perfusion pressure. Int J Ophthalmol, 2017,10(12):1925-1927

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:March 02,2017
  • Revised:June 14,2017
  • Adopted:
  • Online: December 07,2017
  • Published: